Actavis plc, a leading global specialty pharmaceutical company today announced that it has acquired Silom Medical Company, a privately held generic pharmaceutical company focused on developing and marketing therapies in Thailand, for approximately $100…
New report reveals potential breakthrough in pterygium treatment
A new report reveals a potential breakthrough in the treatment of a common eye ailment known as pterygium (Surfer’s eye) that impacts the vision, eye health, and cosmetic appearance of countless sufferers.
Uncategorized
Senate approves one-year SGR patch, delays ICD-10 billing codes
The US Senate voted Monday to approve a one-year temporary legislative patch to avoid looming 24% cuts to physician Medicare payments. The measure also delays the ICD-10 billing codes compliance deadline until 2015
Uncategorized
SLT lowers IOP, has small risk of adverse effects in eyes with moderate POAG
Selective laser trabeculoplasty significantly reduces IOP in eyes with primary open-angle glaucoma without inducing adverse effects, according to a study. The short-term prospective study included 64 eyes with moderate POAG. Medical treatment was not s…
Uncategorized
BLOG: Practice lessons from naval submarines, part 1
Living in San Diego in the shadow of America’s nuclear navy, I once had the privilege of touring a real, live submarine, courtesy of an admiral friend. In 60 minutes, I learned more about the value of staff cross-training than I had learned in all the previous years as a practice consultant. I also picked up lots of other management pearls. I’d like to share a few of these insights with you. Virtually all members of a 135-man submarine crew (U.S. submarines are essentially all-male) are interchangeable, with the exception (Read more...)
BioLight seeks FDA IND approval for subconjunctival Latanoprost controlled release insert Phase I/IIa study
BioLight Israeli Life Sciences Investments Ltd., a firm that invests in, manages and commercializes biomedical innovations grouped into clusters around defined medical conditions, announces that ViSci, its wholly owned subsidiary, has filed an Investig…